logo
Select company
Select metric
-4.01%Shareholder Yield
VS
Market
31
Sector
50
Industry
59
History
33
$ 8.3Close
$ 6.41 - $ 16.8 52-Week Range
Ticker Information

Ticker

GYRE

Company Name

GYRE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GYRE THERAPEUTICS INC - Shareholder Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GYRE - Shareholder Yield Historical data
DateMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity SharesNet Cash Flow - Issuance (Repayment) of Debt SecuritiesNet Cash Flow - Dividends & Other Cash DistributionsShareholder Yield
6/30/2025$ 679.01M$ 27.2M$ 0$ 0-4.01%
3/31/2025$ 893.51M$ 3.44M$ 0$ 0-0.39%
12/31/2024$ 1.15B$ 2.64M$ 0$ 0-0.23%
9/30/2024$ 1.35B$ 1.28M$ 0$ 12.76M-1.04%
6/30/2024$ 971.61M$ 931K$ 0$ 11.26M-1.26%
3/31/2024$ 1.35B$ 656K$ 0$ 7.76M-0.63%
12/31/2023$ 1.5B$ 0$ 0$ 00%
9/30/2023$ 20.47M$ 24K$ 0$ -12.76M62.24%
6/30/2023$ 13.26M$ 6K$ 0$ -56.3M424.56%
3/31/2023$ 8.31M$ 6K$ 0$ -52.8M635.46%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GYRE THERAPEUTICS INC's latest trailing twelve months (TTM) Shareholder Yield stands at -47.03%.
  • Over the past 5 years, GYRE THERAPEUTICS INC's average Shareholder Yield has been 72.63%.
  • The median Shareholder Yield for GYRE THERAPEUTICS INC during this period was -0.71%
  • GYRE THERAPEUTICS INC reached its highest Shareholder Yield over the past 5 years at 635.46%.
  • The lowest Shareholder Yield recorded by GYRE THERAPEUTICS INC in the same timeframe -238.52%

GYRE THERAPEUTICS INC's Shareholder Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Shareholder Yield Benchmarks
CompanyShareholder Yield
PHAT : PHATHOM PHARMACEUTICALS INC -22.22%NAGE : NIAGEN BIOSCIENCE INC -1.55%ANAB : ANAPTYSBIO INC -3.22%TBPH : THERAVANCE BIOPHARMA INC 0.33%URGN : UROGEN PHARMA LTD -4.65%CRMD : CORMEDIX INC -14.38%NRIX : NURIX THERAPEUTICS INC -24.33%ZVRA : ZEVRA THERAPEUTICS INC -10.38%KURA : KURA ONCOLOGY INC -0.71%SAGE : SAGE THERAPEUTICS INC -0.31%

Definition of Shareholder Yield

[Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for GYRE THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 60.38M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 128.39M ]
(=) Shareholder Yield [ -47.03% ]

GYRE - Shareholder Yield, Last 5 years

-238.52%

Minimum

Dec 31, 2021

635.46%

Maximum

Mar 31, 2023

72.63%

Average

-0.71%

Median

Shareholder Yield Benchmark Analysis

The chart above depicts the distribution of Shareholder Yield for companies in the Total Stock Market. The average Shareholder Yield of the companies is 0.57% with a standard deviation of 11.13%.
The following table provides additional summary stats:
Shareholder Yield in the Market:
filtered constituents3.48K
min-33.43%
max34.45%
average0.57%
median1.07%
std11.13%